password

username

• Newsletters
• Senders
• Contribute
• Faq

Newsletter preview

Date:

Thu, October 12, 2006 11:21:37 AM

From:

Outsourcing-Pharma

Subject:

12/10 Cardinal/Wyeth/Outsourcing report/Nicholas Piramal/India/Sigma Pharmaceuticals/Xcelience

Can't read the email below? Click Here

Today on Outsourcing-Pharma.com   >  Cardinal attracts Wyeth as cell line engineering market remains   >  Pharma not using outsourcing to its fullest, says report   >  Nicholas Piramal targets Europe with new innovation centre   >  Sigma makes bid to dominate Australian drug market   >  Xcelience to expand headquarters in Florida

Other top industry news   >  Pfizer pushes forward into vaccine market   >  Eurand to co-develop GSK drug   >  FDA says drug safety reforms   >  Report: FDA needs overhaul in drug safety process

	Outsourcing Pharma
Search Forward to a colleague		Thursday 12 October 2006

	Sponsored by SF-Chem High-quality intermediates SF-Chem is a supplier of high-quality intermediates to customers in the global chemical industry, particularly pharmaceuticals. The company is highly specialised in chlorine and sulfur chemistry. Click Here Access full stories Cardinal attracts Wyeth as cell line engineering market remains Cardinal Health says its experiencing a "robust market" for is its cell line engineering technology, as it attracts the attention of pharma giant Wyeth and executes capacity expansion plans its for full service... Read Pharma not using outsourcing to its fullest, says report According to a new report, pharmaceutical and biotech companies have not fully exploited the potential outsourcing represents... Read Nicholas Piramal targets Europe with new innovation centre In its ambition to become one of the top three global players in custom manufacturing, the UK subsidiary of drug-maker Nicholas Piramal (NPIL) has created a new inovation unit n Europe... Read Sigma makes bid to dominate Australian drug market Australia' Sigma Pharmaceuticals is attempting to take over the reigns of smaller domestic rival Australian Pharmaceutical Industries (API) in a move that if successful, would allow it to control two thirds of... Read Xcelience to expand headquarters in Florida Formulation development company Xcelience has announced its plan to expand its headquarters in Tampa, Florida to meet higher customers demand... Read
	All News Headlines for: October | September | August
	Sponsored by Cardinal Health Cardinal Health enhances drug delivery Cardinal Health is a world leader in patented drug-delivery technologies. We develop and manufacture advanced drug-delivery systems and partner with nearly every major global pharmaceutical company. Click Here

Previous Headlines > Datatrak a€?on tracka&eur ... > Holmes Biopharma gaining Phase ... > RegeneRx seeks CRO to speed up ... > Data warehouse identified as k ... > AAIPharma shows first signs of ... > Agilent chooses Distek to reac ... > Tech Group seeks bigger facili ... > European countries hailed as t ... > GTC and LFB collaborate on tra ... > Inyx buys Pharmapac to enrich ... Product Categories > Product & Supplier News - Contract Manufacturing Related Web Sites > In-PharmaTechnologist.com > DrugResearcher.com > BioPharmaReporter.com > All our Websites

Other top industry news Pfizer pushes forward into vaccine market Pfizer is pushing through into the increasingly profitable vaccine market with the purchase of privately held UK firm PowderMed for an undisclosed sum... Read Eurand to co-develop GSK drug Eurand has signed a $42m licensing deal with GlaxoSmithKline to make a new formulation of one of the British pharma giant' drugs... Read FDA says drug safety reforms The FDA has admitted that more needs to be done to ensure the safe and effective use of prescription drugs, after a report urged the regulator to revamp its drug safety system... Read Report: FDA needs overhaul in drug safety process The FDA has come under scrutiny after a report urged the regulator to implement large reforms to ensure the safety of new prescription drugs... Read Events - Publisher's Choice STAY up-to-date with pharmaceutical Innovations Visit our regularly updated events calendar and learn about important events within the industry today ... Read ELNS & Laboratory Informatics 4 days of interactive sessions and case studies providing the most current assessment of the future of electronic data recording implementation, integ ... Read Sponsored by ScinoPharm Taiwan® Experts in small molecule custom synthesis ScinoPharm Taiwan®, Ltd. is a process research, development, and manufacturing service provider of active pharmaceutical ingredients (APIs) to the global pharmaceutical industry. Our expertise is in small molecule custom synthesis. Click Here Forward to a colleague

Subscribe to other Decision News Media e-newsletters - Pharmaceuticals Breaking news Pharmaceutical Technology Drug Discovery Outsourcing Pharma Biopharmaceutical Science and Business Laboratory Equipment Access Decision News Media e-newsletters for the food, beverage & nutition industries click here

	To continue to receive this newsletter in your inbox, please add newsletter@outsourcing-pharma.com to your address book
	Update preferences | Change your email address | ***
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2006 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com

 

© 2007 - The Code Kitchen for interface design and text. Newsletter content remains the copyright of the respective publishers.
Contact: info@newsletterarchive.org